Who actually makes the skincare on a Tokyo drugstore shelf?

The name printed largest on a bottle of Japanese drugstore skincare is frequently not the name of the company that made it, and often not the name of any company at all — it is a trademark. Japanese law does not require the maker to be identified on the pack; it requires something else entirely, the 製造販売業者, the licensed company that takes legal responsibility for putting that product on the market, printed in small type on the back.

Once you know that those are two different roles, the shelf changes shape. Dozens of brands that look like separate companies resolve into a smaller number of responsible parties, a much smaller number of factories, and a contract-manufacturing industry that Japan's own trade ministry values at JPY 345.6 billion a year.

This article is about who stands behind a product legally and industrially, and how the pack lets you see it. It does not recommend or compare products, it makes no claim about whether any product works, and it gives no medical or dermatological advice of any kind. It also does not cover the statutory shelf categories (化粧品, 医薬部外品, the numbered medicine classes) or the tax-free system, which are separate subjects.

What does the back name?

Article 61 of the Act on Securing Quality, Efficacy and Safety of Products Including Pharmaceuticals and Medical Devices — 薬機法 — lists exactly what a cosmetic's direct container or wrapping must carry, and the first item is the name and address of the 製造販売業者 (e-Gov 法令検索, 医薬品医療機器等法第61条, read 15 September 2026). The other required items are the product name as notified, the manufacturing number or code, designated ingredient names, an expiry date for designated products, and anything a product-specific standard adds.

Two absences in that list do more work than the entries. There is no requirement to name the factory. There is no requirement to state the country of origin.

The address is not what most shoppers assume either. The Tokyo Metropolitan Institute of Public Health, which supervises labelling compliance for companies licensed in Tokyo, states that the address required by Article 61 is the location of the office where the 総括製造販売責任者 — the marketing authorisation holder's chief quality officer — performs their duties (東京都健康安全研究センター, 化粧品の表示, checked 15 September 2026). It is a head-office address, not a plant address, and a Tokyo address on a bottle tells you where a responsible person sits, not where a mixing tank stands.

The table below maps each field you can actually see on a Japanese cosmetic pack to its legal name and to what it does and does not reveal about who made the product.

The ingredient list deserves its own note, because Japan's rule is unusually complete and it is the second real piece of evidence the pack gives you. Cosmetics must in principle display every compounded ingredient, and a 2001 ministry notice sets out how: names in Japanese, in descending order of quantity, with ingredients at or below 1% and colourants allowed in any order at the end, carry-over traces exempt, premixes broken out into their components, and fragrance permitted as the single word 香料 (東京都健康安全研究センター, citing 平成13年3月6日医薬審発第163号, checked 15 September 2026).

Who is responsible for what?

Japanese law splits the work of putting a cosmetic on the shelf into licensed roles, and the split is the reason the pack looks the way it does. Article 12 requires a 化粧品製造販売業許可 to place cosmetics on the market; Article 13 requires a separate 製造業許可 to manufacture them, granted by production site rather than by company (e-Gov 法令検索, read 15 September 2026).

The definition that ties it together sits in Article 2, paragraph 13: 製造販売 means selling products you manufactured "including cases where manufacture is commissioned to another party, and excluding cases where you are commissioned by another party". A marketing authorisation holder is therefore, by definition, allowed to own no factory at all. A contract manufacturer is, by the same definition, not doing 製造販売 when it makes goods to another company's order — which is precisely why its name need not appear.

The chief quality officer is not a formality. Article 17 requires the marketing authorisation holder to appoint one, and gives that person a duty to state their opinion in writing to the company when it is necessary for fair and proper quality management — a statutory channel for an employee to put an objection on the record against their own employer.

On the manufacturing side, the licence is finer-grained than most shoppers imagine. Tokyo's supervising body distinguishes two 製造業 categories: one covering all or part of the manufacturing process, and one covering packaging, labelling and storage only (東京都健康安全研究センター, 化粧品製造業のページ, checked 15 September 2026). A company can hold a manufacturing licence and never mix a formula. Filling, boxing and labelling are licensed manufacturing acts in their own right.

Why is no factory named?

The factory vanished from Japanese cosmetics packs as the direct result of a 2005 legal change, and Japan's own trade ministry says so in writing. A report commissioned by the Ministry of Economy, Trade and Industry and prepared by KPMG AZSA, dated 28 February 2025, records that the 2005 amendment to the Pharmaceutical Affairs Act separated the 製造業 licence from the new 製造販売業 licence, and that as a consequence "if the commissioning party holds a marketing authorisation licence, it is no longer necessary to display the name of the contract manufacturer on the product", which expanded outsourcing by large brand manufacturers that own their own plants (経済産業省／あずさ監査法人, 化粧品におけるOEM/ODM/原料製造の市場動向調査, read 15 September 2026).

The same report places a second change alongside it. The 2001 amendment made full ingredient disclosure compulsory for cosmetics and replaced ministerial approval of each product with a notification system, which sped up launches and encouraged new ingredient development. Taken together, the two changes describe the modern Japanese cosmetics shelf: more transparency about what is in the bottle, less about who filled it.

One narrow exception survives, and it is the tell that proves the rule. Where a cosmetic is sold from one licensed company to another as bulk for further manufacture and carries the words 製造専用 on the container, Article 61's first item switches from 製造販売業者 to 製造業者 — the factory's name replaces the responsible company's (東京都健康安全研究センター, checked 15 September 2026). Those containers move between companies and never reach a drugstore shelf.

How large is contract manufacturing?

Contract manufacturing is a mainstream part of the Japanese cosmetics industry, not a budget corner of it, and the government-commissioned figures give its size. The METI report puts the domestic cosmetics contract-manufacturing market at JPY 345.6 billion in FY2023, having first passed JPY 300 billion in 2018, and states that the top ten firms hold about 60% of it while many of the leading companies are unlisted small and mid-sized businesses (経済産業省／あずさ監査法人, published 28 February 2025, read 15 September 2026).

For scale on the other side of the ledger, the Japan Cosmetic Industry Association reports cosmetics shipments of JPY 1,374.5 billion in 2024, up 5.5% year on year, drawing on METI's production statistics (日本化粧品工業会, 化粧品出荷, page dated 27 October 2025, checked 15 September 2026). A separate METI briefing dated 8 December 2025 describes the industry as polarised between a few large companies and a great many small ones, with roughly 3,000 companies accounting for about half of the prestige segment (経済産業省, 化粧品製造業をめぐる状況, read 15 September 2026).

The report also names the largest contract manufacturers and their FY2023 market shares, sourced to Yano Research Institute. The table below lists the five largest, with what each company or the report states about it — and nothing more, because a market share is not a client list.

Two details in that table are worth separating from the numbers. The shares come from a market research series quoted inside a government-commissioned report, not from company filings, and the market moved after the snapshot: the same report notes that the largest firm acquired the second-largest in June 2024, and Tokiwa's own corporate history records a change of shareholders and the start of a partnership with 日本コルマーホールディングス in July 2024 (株式会社トキワ, 会社概要・沿革, checked 15 September 2026; TOA株式会社, press release, 23 May 2024).

The report is also useful on which products get outsourced. It states that skincare tends to be kept in-house by large brand manufacturers as a core strength, while makeup — many variants, small runs, complex assembly — has been outsourced by large brands since comparatively early, and that haircare is often outsourced because hair colourants and oils are classed as hazardous materials requiring specialised plant. Read against the drugstore shelf, that means the category most likely to be contract-made is not necessarily the cheapest one.

Foreign-headquartered contract manufacturers operate in this market too. COSMAX, a Korean-headquartered ODM group, lists an office in Nihonbashi, Tokyo among its group locations and describes itself as providing services from formulation development to branding (COSMAX, Cosmax Group, checked 15 September 2026). That is a company statement about itself, and it is all this article will say: no source read here connects that group, or any other named contract manufacturer, to any named Japanese drugstore brand.

Who makes the chains' brands?

Japan's drugstore chains sell large ranges of own-brand skincare, and their own published materials name the brands without naming the makers. Matsukiyo Cocokara & Company's online store lists sixteen original brands, among them matsukiyo, matsukiyo LAB, ARGELAN, nake, Retino Time and Recipeo, under an "original brands" heading, with no manufacturing information attached to any of them (マツキヨココカラオンライン, ブランド特集, checked 15 September 2026). Welcia's own-brand site for からだWelcia and くらしWelcia explains the products as developed from customer feedback and names no production partner (ウエルシア薬局, checked 15 September 2026).

Where a partner is named, it is usually in a press release, and it is a brand company rather than a contract manufacturer. Matsukiyo Cocokara announced on 7 February 2024 that its new cosmetics brand nake was co-developed with the cosmetics maker 伊勢半, and that the range would go on sale from 11 March 2024 across its network of more than 3,400 stores (株式会社マツキヨココカラ＆カンパニー, 7 February 2024). Welcia announced on 10 October 2024 that a からだWelcia point-makeup remover was co-developed with 株式会社マンダム (ウエルシア薬局株式会社, 10 October 2024). Neither release states which plant produced the goods, and neither states who holds the marketing authorisation.

The METI report explains why the chains need partners at all: it identifies supporting retailers' private-brand development as one of the roles contract manufacturers took on after the 2005 reform, alongside turning the technical ideas of companies from other industries into sellable products. The fair-trade code goes further and writes the structure into its own definitions, treating a business that commissions cosmetics from a marketing authorisation holder and sells them under its own trademark or name as equivalent to a manufacturer for labelling purposes (化粧品公正取引協議会, 施行規則第1条, checked 15 September 2026). That sentence is the private-brand model described in regulatory language.

For a sense of how much shelf this covers, Sundrug's own company page reports 886 directly operated stores, 671 subsidiary stores and 37 franchise and other stores as of 31 March 2026 (株式会社サンドラッグ, 企業概要, checked 15 September 2026). Cocokara Fine is no longer an independent chain in this context; it merged into Matsukiyo Cocokara & Company, which took its current name on 1 October 2021.

Does it prove Japanese manufacture?

A Japanese brand name, a Japanese company on the back and Japanese-language packaging do not, on their own, establish where a product was made. 薬機法 does not require a country of origin on cosmetics at all — it is absent from the Article 61 list — and the Consumer Affairs Agency's origin rule under the Act against Unjustifiable Premiums and Misleading Representations, 昭和48年公正取引委員会告示第34号, prohibits misleading origin representations rather than requiring origin to be stated (消費者庁, 商品の原産国に関する不当な表示, checked 15 September 2026). That notification defines a product's country of origin as the country where the act producing a substantial change to its content took place.

What fills the gap is the industry's own fair-trade code, agreed under the same act. Article 4 of 化粧品の表示に関する公正競争規約 requires participating businesses to display, in Japanese and legibly, the type name, sales name, the 製造販売業者's name and address, contents, lot code, expiry where applicable, designated ingredients, an enquiry contact — and the country of origin, except where the product is clearly recognised by consumers as domestic (化粧品公正取引協議会, checked 15 September 2026).

The code's implementing rules then define origin tightly enough to be useful. The country of origin is the country where the establishment that manufactured the product is located, and manufacturing explicitly excludes labelling, applying outer packaging, and merely assembling or combining products. Most pointedly, a cosmetic where only the repackaging step was carried out in Japan is treated as a foreign product and must be labelled with its actual origin country alongside the 製造販売元 (化粧品公正取引協議会, 施行規則第8条, checked 15 September 2026).

The absence to keep in mind is the scope of that code. It binds businesses that participate in it, not every seller in Japan, and its origin requirement carves out products consumers would obviously take as domestic. So the presence of 原産国 or Made in Japan on a pack is meaningful information; the absence of any origin line is not proof of anything.

How do you check a shelf?

Checking who stands behind a product takes under a minute per item and needs only your eyes and a phone camera. Work through it in the aisle, in this order.

1. Turn the pack over and find the small block of text. You are looking for a company name and address, usually preceded by 製造販売元. That is the 製造販売業者 required by Article 61, and it is the only company the law guarantees will be there.
2. Read the name against the brand on the front. If they differ, the brand is being marketed by another company — extremely common, and not a defect. If they match, the brand owner is also the licence holder.
3. Compare packs across the aisle. Write down the 製造販売元 from several products in different brands. Where the same company appears behind two brands, you have found a real shared responsible party rather than an internet rumour.
4. Treat the address as a head office. The Tokyo Metropolitan Institute of Public Health states it is the office of the chief quality officer, so it tells you where the company is run, not where the product was made.
5. Look for 原産国 or Made in Japan, and note its absence too. Where present, it names the country of the plant that made the contents, not the country that boxed them. Where absent, draw no conclusion.
6. Read the ingredient list as the formula, not the factory. It is complete down to 1% by rule, which makes it good evidence about composition and no evidence at all about production site.
7. If you need the maker, use the enquiry contact. The fair-trade code requires a contact able to answer questions about the labelled items. A company may decline to name its contract manufacturer, and declining is lawful.
8. Photograph the back panel before you leave the shop. The 製造販売元 block, the lot code and the ingredient list are the record; the carton usually gets thrown away, and none of this is reliably reproduced online in English.

There is a matching list of things this method cannot do, and being blunt about it saves you from bad conclusions. It cannot identify the factory. It cannot tell you whether a product was made in-house or on contract. It cannot rank two products by quality, and no part of Japan's labelling system was designed to let it.

What could not be verified?

Several things this article would have liked to state could not be sourced, and naming them is more useful than guessing. No brand-to-factory mapping was verified for any Japanese drugstore skincare product. The METI-commissioned report names leading contract manufacturers and their market shares but no client brands; TOA and Tokiwa describe their own businesses without naming customers; and the drugstore chains' own pages and releases name co-development partners in some cases but never the production site. Any English-language article asserting that a specific brand is made by a specific factory is making a claim this article's sources cannot support.

No public, consumer-facing register linking a cosmetic brand to its marketing authorisation holder or to a production site was located. Licences are issued by prefectural governors for cosmetics, and Tokyo's own pharmaceutical-affairs pages document the application procedures without publishing a searchable list of licensed companies for the public. The practical consequence is that the pack itself is the primary document available to you.

The share of drugstore shelf space or sales accounted for by private brands could not be confirmed from any chain's own disclosure read here, and no chain page consulted stated who manufactures its own-brand skincare. Store counts were taken where the company publishes them with a date — Sundrug's as of 31 March 2026, Matsukiyo Cocokara's "more than 3,400" as stated in its own February 2024 release — and no current company-published figure with an as-of date was located for Welcia's store network.

Finally, no source consulted supports any quality inference in either direction. Contract manufacturing is not evidence of a cheaper product, in-house manufacturing is not evidence of a better one, and the fact that two brands share a 製造販売業者 says nothing about whether their contents resemble each other. The labelling system exists to fix responsibility, not to rank products — and responsibility, precisely located, is the one thing the back of a Japanese pack will always give you.